These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

333 related articles for article (PubMed ID: 28356027)

  • 1. Natural Polyphenols in the Treatment of Alzheimer's Disease.
    Syarifah-Noratiqah SB; Naina-Mohamed I; Zulfarina MS; Qodriyah HMS
    Curr Drug Targets; 2018; 19(8):927-937. PubMed ID: 28356027
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dietary polyphenol-derived protection against neurotoxic β-amyloid protein: from molecular to clinical.
    Smid SD; Maag JL; Musgrave IF
    Food Funct; 2012 Dec; 3(12):1242-50. PubMed ID: 22929970
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Potential Role of (-)-Epigallocatechin-3-Gallate (EGCG) in the Secondary Prevention of Alzheimer Disease.
    Xicota L; Rodriguez-Morato J; Dierssen M; de la Torre R
    Curr Drug Targets; 2017; 18(2):174-195. PubMed ID: 26302801
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Insights into the Effect of Curcumin and (-)-Epigallocatechin-3-Gallate on the Aggregation of Aβ(1-40) Monomers by Means of Molecular Dynamics.
    Tavanti F; Pedone A; Menziani MC
    Int J Mol Sci; 2020 Jul; 21(15):. PubMed ID: 32751722
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An Increasing Role of Polyphenols as Novel Therapeutics for Alzheimer's: A Review.
    Karim N; Khan H; Khan I; Guo O; Sobarzo-Sánchez E; Rastrelli L; Kamal MA
    Med Chem; 2020; 16(8):1007-1021. PubMed ID: 31702507
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Resveratrol activation of AMPK-dependent pathways is neuroprotective in human neural stem cells against amyloid-beta-induced inflammation and oxidative stress.
    Chiang MC; Nicol CJ; Cheng YC
    Neurochem Int; 2018 May; 115():1-10. PubMed ID: 28989083
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neuroprotective potentials of Lead phytochemicals against Alzheimer's disease with focus on oxidative stress-mediated signaling pathways: Pharmacokinetic challenges, target specificity, clinical trials and future perspectives.
    Ayaz M; Mosa OF; Nawaz A; Hamdoon AAE; Elkhalifa MEM; Sadiq A; Ullah F; Ahmed A; Kabra A; Khan H; Murthy HCA
    Phytomedicine; 2024 Feb; 124():155272. PubMed ID: 38181530
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Metal chelation, radical scavenging and inhibition of Aβ₄₂ fibrillation by food constituents in relation to Alzheimer's disease.
    Chan S; Kantham S; Rao VM; Palanivelu MK; Pham HL; Shaw PN; McGeary RP; Ross BP
    Food Chem; 2016 May; 199():185-94. PubMed ID: 26775960
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tea polyphenols as multi-target therapeutics for Alzheimer's disease: An in silico study.
    Mazumder MK; Choudhury S
    Med Hypotheses; 2019 Apr; 125():94-99. PubMed ID: 30902161
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Possible involvement of programmed cell death pathways in the neuroprotective action of polyphenols.
    Bastianetto S; Krantic S; Chabot JG; Quirion R
    Curr Alzheimer Res; 2011 Aug; 8(5):445-51. PubMed ID: 21605053
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cholinesterase targeting by polyphenols: A therapeutic approach for the treatment of Alzheimer's disease.
    Jabir NR; Khan FR; Tabrez S
    CNS Neurosci Ther; 2018 Sep; 24(9):753-762. PubMed ID: 29770579
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Curcumin-induced upregulation of the anti-tau cochaperone BAG2 in primary rat cortical neurons.
    Patil SP; Tran N; Geekiyanage H; Liu L; Chan C
    Neurosci Lett; 2013 Oct; 554():121-5. PubMed ID: 24035895
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The role of polyphenols in the modulation of sirtuins and other pathways involved in Alzheimer's disease.
    Jayasena T; Poljak A; Smythe G; Braidy N; Münch G; Sachdev P
    Ageing Res Rev; 2013 Sep; 12(4):867-83. PubMed ID: 23831960
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Naturally occurring phytochemicals for the prevention of Alzheimer's disease.
    Kim J; Lee HJ; Lee KW
    J Neurochem; 2010 Mar; 112(6):1415-30. PubMed ID: 20050972
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The pharmacological activity of epigallocatechin-3-gallate (EGCG) on Alzheimer's disease animal model: A systematic review.
    Zhang S; Zhu Q; Chen JY; OuYang D; Lu JH
    Phytomedicine; 2020 Dec; 79():153316. PubMed ID: 32942205
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Examining the potential clinical value of curcumin in the prevention and diagnosis of Alzheimer's disease.
    Goozee KG; Shah TM; Sohrabi HR; Rainey-Smith SR; Brown B; Verdile G; Martins RN
    Br J Nutr; 2016 Feb; 115(3):449-65. PubMed ID: 26652155
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synthetic Curcumin Analogs as Inhibitors of β -Amyloid Peptide Aggregation: Potential Therapeutic and Diagnostic Agents for Alzheimer's Disease.
    Bukhari SN; Jantan I
    Mini Rev Med Chem; 2015; 15(13):1110-21. PubMed ID: 26420724
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Research on EGCG improving the degenerative changes of the brain in AD model mice induced with chemical drugs].
    He M; Liu MY; Wang S; Tang QS; Yao WF; Zhao HS; Wei MJ
    Zhong Yao Cai; 2012 Oct; 35(10):1641-4. PubMed ID: 23627134
    [TBL] [Abstract][Full Text] [Related]  

  • 19. (-)-Epigallocatechin-3-gallate ameliorates memory impairment and rescues the abnormal synaptic protein levels in the frontal cortex and hippocampus in a mouse model of Alzheimer's disease.
    Guo Y; Zhao Y; Nan Y; Wang X; Chen Y; Wang S
    Neuroreport; 2017 Jul; 28(10):590-597. PubMed ID: 28520620
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Potential neuroprotective properties of epigallocatechin-3-gallate (EGCG).
    Singh NA; Mandal AK; Khan ZA
    Nutr J; 2016 Jun; 15(1):60. PubMed ID: 27268025
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.